In order to stay as infection-free as possible, people with cystic fibrosis (CF) receive regular courses of intravenous antibiotics, usually delivered in hospital.
However, the rise in infections that are resistant to antibiotics, such as MRSA, and ongoing problems with bacteria such as Burkholderia cepacia complex, Pseudomonas aeruginosa and Mycobacterium abscessus means that more and better antibiotics are needed. Find out more about how cystic fibrosis affects the lungs and how the risk of passing lung infections from one person to another (cross-infection) affects people with the condition.
We continue to fund research aimed at understanding these bacteria and other micro-organisms and finding better ways to fight them.
Read more about the projects below: